How does that shared language and perhaps not always shared understanding or different viewpoints How does that influence how you build your company quality standards into your hydrogels and finally interact with your customers? First of

all, yes, originally scientists, but I have been working a long time in the industry, so I'm very well aware of those quality standards.

Previous company I had, we were also ISO certified 13485, so that's not easy.

One of the things is start early.

It's important because then you create a culture that everybody who steps into the company becomes aware of the fact that this is part of our DNA to do this properly.

Secondly, I have a strong belief, especially Matt, but we have also different people in the group now.

Clarissa from the cell part and Georgia was recently joined.

And I think that these are two strengths that we have and playing off of each other really works for a lot of startups, but ours especially.

Tell us a bit more why you started out with that and what drove that pivot.

I think it was a good start to think about that part on 3D bioprinting.

But what immediately attracted my attention was that the conditions for the cell growth were also optimal.

So Matt showed in some articles and publications that the morphology and the physiological characteristics of the cells were also much better.

And then last year, I was on a trade mission of the Dutch Ministry of Economic Affairs in Switzerland, listening to stories of former companies and starter companies.

And then I started realizing that one of the problems that industry is facing is how can we make, not only have that matrix and hydrogels for those cells, but also to use them in high throughput screening systems.

It's really a hassle at this moment.

As you're further developing this technology, I'd be curious about what is your strategy to get early customer feedback, to really understand what your target audience needs? What is your approach there? We work with academia